AJO LP’s Teva Pharmaceuticals TEVA Stock Holding History

AJO LP’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-80,543	Closed	-$1.24M	–	741
2018 Q4	$1.24M	Sell	80,543 -50,169	-38%	-$1.03M	0.01%	492
2018 Q3	$2.82M	Buy	130,712 +30,982	+31%	+$719K	0.01%	428
2018 Q2	$2.42M	Buy	+99,730	New	+$2.03M	0.01%	442
2016 Q4	–	Sell	-28,225	Closed	-$1.3M	–	565
2016 Q3	$1.3M	Buy	28,225 +14,824	+111%	+$773K	0.01%	374
2016 Q2	$673K	Sell	13,401 -9,258	-41%	-$493K	﹤0.01%	425
2016 Q1	$1.21M	Sell	22,659 -39,913	-64%	-$2.34M	0.01%	386
2015 Q4	$4.11M	Sell	62,572 -19,088	-23%	-$1.18M	0.02%	308
2015 Q3	$4.61M	Buy	81,660 +7,000	+9%	+$454K	0.02%	305
2015 Q2	$4.41M	Buy	74,660 +52,770	+241%	+$3.26M	0.02%	322
2015 Q1	$1.36M	Buy	21,890 +8,780	+67%	+$510K	0.01%	382
2014 Q4	$754K	Buy	+13,110	New	+$730K	﹤0.01%	385

Other funds holding TEVA

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACM

Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AJO LP's TEVA Position: Q1 2019 in Review

AJO LP sold out of Teva Pharmaceuticals (TEVA) in Q1 2019, closing a stake of 80,543 shares — an estimated $1.24M sold.

AJO LP first reported a position in TEVA in Q4 2014 and held it in 11 quarters. The position peaked at $4.61M in Q3 2015. 521 funds tracked by Wall St. Rank hold TEVA as of Q1 2019.

AJO LP reported no remaining Teva Pharmaceuticals position as of Q1 2019 after selling out during the quarter.
AJO LP sold 80,543 Teva Pharmaceuticals shares in Q1 2019, an estimated $1.24M.
AJO LP first reported a position in Teva Pharmaceuticals in Q4 2014 and held it in 11 quarters.
AJO LP's Teva Pharmaceuticals position peaked at $4.61M in Q3 2015.
521 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2019.

Based on AJO LP's 13F filing for Q1 2019, filed 10 May 2019.